Loading provider…
Loading provider…
Dermatology Physician in Houston, TX
NPI: 1003876285Primary Practice Location
Sagis, PLLC
4131 Directors Row, Houston, TX
Primary Employer
Alliance Pathology Consultants PA
HQ Phone
Get M.D. Howard's Phone Numberphone_androidMobile
Get M.D. Howard's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardTX State Medical License
TX State Medical License
1988 - 2027
OK State Medical License
1988 - 1998

American Board of Dermatology
Dermatology

American Board of Dermatology
Dermatopathology
OU College of Medicine
medicine.ouhsc.edu
Fellowship • Dermatopathology
1991 - 1992
McGovern Medical School
med.uth.edu
Medical School
Until 1987
University of Oklahoma Health Sciences Center
Residency • Dermatology
1988 - 1991
University of Arkansas for Medical Sciences (UAMS) College of Medicine
Internship • Transitional Year
1987 - 1988
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 88305Pathology examination of tissue using a microscope, intermediate complexity | 1,843 | 3,497 |
| 2 | 99213Established patient office or other outpatient visit, typically 15 minutes | 469 | 758 |
| 3 | 17000Destruction of skin growth | 327 | 511 |
| 4 | 17003Destruction of 2-14 skin growths | 266 | 1,544 |
| 5 | 99214Established patient office or other outpatient visit, 30-39 minutes | 236 | 341 |
A case of indeterminate dendritic cell tumor presenting with leonine facies
Authors: Jonathan Curry, Madeleine Duvic, Carlos Torres Cabala, Doina Ivan
Journal: J Cutan Pathol
Publication Date: 2015-09-11
A case of indeterminate dendritic cell tumor presenting with leonine facies.
Authors: Chee Oh, Doina Ivan, Jonathan Curry, Rachel Ellis, Howard Gerber, Madeleine Duvic, Carlos Torres Cabala
Publication Date: 2014-10-14
Microreticular perineurioma: A new morphological subtype of a rare entity.
Lead Sponsor: Regeneron Pharmaceuticals
Collaborators: Sanofi
Intervention / Treatment: DRUG: Dupilumab, DEVICE: Prefilled syringe, DEVICE: Auto-injector Device